Cytotoxicity and effect on wound re‐epithelialization after topical administration of tranexamic acid
Background Topical administration of tranexamic acid (TXA) reduces bleeding from surgical wounds similarly to intravenous use, but with negligible risk of adverse systemic events. Topical use is expanding, but is off‐label. Surgeons lack guidelines regarding safe topical dosages and modes of adminis...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2019-12-01
|
Series: | BJS Open |
Online Access: | https://doi.org/10.1002/bjs5.50192 |